Stock Market Updates: Bolt Biotherapeutics Narrows Losses and Reduces Cash Burn
Stock market updates from the biotechnology sector are drawing attention to Bolt Biotherapeutics after the company reported first-quarter 2026 financial results showing a narrower net loss, lower operating cash use, and a relatively stable cash position compared with the start of the year. According to the original GlobeNewswire report published
